← All Sponsors

SPONSOR

NHS Greater Glasgow and Clyde

Total Trials

3

Recruiting

3

Phases

Phase 3

Conditions studied: Sepsis SCN1A Dravet Syndrome Epilepsy Pharmacogenomic Drug Interaction

NCT05179499 Phase 3

Early Vasopressors in Sepsis

SCN1A Horizons A Natural History Study of SCN1A-related Epilepsies in the United Kingdom

PRE-EMPTIVE PHARMACOGENOMICS IN ACUTE CARE SETTINGS WITH HEALTH ECONOMIC EVALUATIONS (PHOENIX TRIAL)

Pharmacogenomic Drug Interaction